Argenx
ARGX
#476
Rank
โ‚น4.724 T
Marketcap
โ‚น76,353
Share price
1.70%
Change (1 day)
40.67%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น4.724 Trillion

As of February 2026 Argenx has a market cap of โ‚น4.724 Trillion. This makes Argenx the world's 476th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น4.724 T0.03%
2025โ‚น4.723 T47.02%
2024โ‚น3.212 T71.02%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.7%
2021โ‚น1.368 T33.48%
2020โ‚น1.025 T109.06%
2019โ‚น490.51 B100.08%
2018โ‚น245.15 B91.51%
2017โ‚น128.01 B
2014โ‚น9.22 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Argenx was reported to be:

โ‚น4.656 Trillion
by Nasdaq info icon info icon
โ‚น4.724 Trillion
by CompaniesMarketCap info icon info icon